Literature DB >> 26786536

The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis.

M A L Tanay1, J Armes1, E Ream2.   

Abstract

The aim of this review was to systematically identify, appraise and synthesise qualitative research evidence on the experience of adult cancer patients living with chemotherapy-induced peripheral neuropathy (CIPN). A systematic search of the literature was performed in September 2015. Qualitative studies were included if they investigated CIPN and patient experience. Quality of the articles was appraised using an adapted version of the Critical Appraisal Skill Programme Checklist for Qualitative Research (CASP 2014). Themes were identified using the thematic synthesis approach proposed by Thomas and Harden [BMC Medical Research Methodology 8 (2008) 45]. Five articles presented findings generated by 88 patients who had all received neurotoxic chemotherapy. Sample sizes from included studies varied from 1 to 28 patients; all studies originated from America and were published between 2005 and 2015. Four analytical themes emerged: (1) CIPN is an unclear experience, (2) a less important risk, (3) impact on quality of life and (4) a feature of cancer survivorship. In conducting this synthesis, the lack of qualitative evidence in this specific condition is evident. Further studies are needed outside of America, to focus on CIPN risk communication approaches by healthcare professionals, patient understanding and perception of CIPN risk and interventions to promote early detection of CIPN including effective reporting and assessment.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  CIPN; cancer; chemotherapy-induced peripheral neuropathy; patient experience; thematic synthesis

Mesh:

Substances:

Year:  2016        PMID: 26786536     DOI: 10.1111/ecc.12443

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  17 in total

1.  Examining the Impact of a Web-Based Intervention to Promote Patient Activation in Chemotherapy-Induced Peripheral Neuropathy Assessment and Management.

Authors:  Robert Knoerl; Deborah Lee; James Yang; Celia Bridges; Grace Kanzawa-Lee; G Lita Smith; Ellen M Lavoie Smith
Journal:  J Cancer Educ       Date:  2018-10       Impact factor: 2.037

Review 2.  Making Cancer Rehabilitation Services Work for Cancer Patients: Recommendations for Research and Practice to Improve Employment Outcomes.

Authors:  Catherine M Alfano; Erin E Kent; Lynne S Padgett; Melvin Grimes; Janet S de Moor
Journal:  PM R       Date:  2017-09       Impact factor: 2.298

3.  Characterizing patient-clinician chemotherapy-induced peripheral neuropathy assessment and management communication approaches.

Authors:  Robert Knoerl; Ellen M L Smith; Amy Han; Allison Doe; Katelyn Scott; Donna L Berry
Journal:  Patient Educ Couns       Date:  2019-04-09

4.  Psychosocial adaptation and influencing factors among patients with chemotherapy-induced peripheral neuropathy.

Authors:  Xiao Zhou; Dong-Yang Wang; Cai-Yan Ding; Hui Liu; Zhi-Qin Sun
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

5.  Clinician and patient experiences when providing and receiving information and support for managing chemotherapy-induced peripheral neuropathy: A qualitative multiple methods study.

Authors:  Mary Anne Lagmay Tanay; Glenn Robert; Anne Marie Rafferty; Rona Moss-Morris; Jo Armes
Journal:  Eur J Cancer Care (Engl)       Date:  2021-10-12       Impact factor: 2.328

6.  Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment.

Authors:  Noah R Zanville; Kelly N H Nudelman; Dori J Smith; Diane Von Ah; Brenna C McDonald; Victoria L Champion; Andrew J Saykin
Journal:  Support Care Cancer       Date:  2016-07-28       Impact factor: 3.603

7.  Daily activity, mood, and quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy: A mediation effect analysis.

Authors:  Ling-Chun Lu; Shiow-Luan Tsay; Sou-Yi Chang; Chung-Ming Chen; Chieh-Yu Liu
Journal:  Cancer Med       Date:  2019-02-11       Impact factor: 4.452

8.  Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time.

Authors:  Mian Wang; Hui Lin Cheng; Violeta Lopez; Raghav Sundar; Janelle Yorke; Alex Molassiotis
Journal:  BMC Cancer       Date:  2019-11-27       Impact factor: 4.430

9.  Exploring the impact of a decision support algorithm to improve clinicians' chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study.

Authors:  Robert Knoerl; Emanuele Mazzola; Fangxin Hong; Elahe Salehi; Nadine McCleary; Jennifer Ligibel; Kaitlen Reyes; Donna L Berry
Journal:  BMC Cancer       Date:  2021-03-06       Impact factor: 4.430

Review 10.  Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy.

Authors:  Kinga Sałat
Journal:  Pharmacol Rep       Date:  2020-05-11       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.